Latest Infratil (NZX:IFT) News

Small-cap resources led the week, while takeover offers and defence contracts added support across the market.
Investors still had to weigh approvals, cash needs and project delivery against strong headline results.

Listed funds led the week as Cadence and Pengana gained, while Infratil fell despite raising its earnings outlook. AI infrastructure, bank consolidation and new fund structures gave investors plenty to weigh.

Infratil has raised FY27 earnings guidance as data-centre demand accelerates across CDC and Longroad, with AI infrastructure now representing 73% of its NZ$22 billion asset base. The company is also sharpening its strategy around scaled growth platforms, contracted cash flows and selective new investments.

CDC’s independent valuation jumped 23.6% to a mid-point of A$18.5 billion, propelled by contracted capacity exceeding 1GW and a major pipeline expansion to 3.9GW. Infratil’s nearly 50% stake now values at over A$9.2 billion.

Dealmaking and capital moves drove the week in financials, while one regulatory shock hit hard. PEXA slumped, but Magellan, Euroz Hartleys and several smaller finance names rose on mergers, asset sales and balance-sheet updates.

Infratil Limited has issued nearly 2.8 million new ordinary shares under its Dividend Reinvestment Plan at an issue price of NZD 14.70 each, expanding its capital base without altering shareholder rank.

Speculative small caps drove the week, with Tasman Resources, Solis Minerals and Lithium Energy leading the board after funding, drilling and asset sale updates. At the other end, ASX Ltd and Arafura Rare Earths fell hard as investors reacted to higher costs and fresh equity issuance.

Infratil posted an 11% rise in operational EBITDAF to NZ$989 million in FY26, fuelled by a record 555MW CDC data centre contract and a 170% EBITDAF jump at Longroad Energy. The company refined its portfolio with over NZ$600 million in divestments and secured a BBB+ credit rating, underpinning a strong FY27 outlook.